Skip to main content

Pharmacy

By Jeff Lagasse | 12:12 pm | July 25, 2023
The Commission rescinded earlier guidance that was opposed to increased regulatory oversight and transparency of PBMs.
By Jeff Lagasse | 12:37 pm | July 19, 2023
The administration wants to educate consumers about the new Medicare prescription drug benefits under the Inflation Reduction Act.
By Jeff Lagasse | 10:01 am | July 14, 2023
Nonprescription availability may improve access, the FDA said, by allowing people to obtain it without first having to see a provider.
By HIMSS TV | 06:00 am | July 13, 2023
<p>Pharma U offers 10 weeks of education, from how drugs are made to mentoring and coaching, says Naomi Fried, CEO and founder of digital health accelerator PharmStars.</p>
By Jeff Lagasse | 11:36 am | July 12, 2023
Data showed a 16.6% increase in the price of drugs in shortage, driven mostly by an increase in the price of generics.
By Jeff Lagasse | 09:45 am | July 12, 2023
By adding clinically equivalent biosimilars to its formulary, Express Scripts said it can drive greater savings for its clients.
By Susan Morse | 05:35 pm | July 07, 2023
Aspects of this proposed policy will affect nearly all hospitals paid under the Outpatient Prospective Payment System, CMS says.
By Susan Morse | 11:15 am | July 07, 2023
Leqembi is the first amyloid beta-directed antibody to be converted from an accelerated approval to a traditional approval.
By Susan Morse | 10:12 am | June 30, 2023
The list of the first 10 drugs covered under Part D selected for initial price applicability year 2026 will be announced September 1.
By Jeff Lagasse | 12:55 pm | June 23, 2023
Medicare will cover drugs with traditional FDA approval when a physician and clinical team participates in a registry.